Insider trade

Becton Dickinson (BDX): Officer sold ~$94K

Michael David Garrison, Officer at Becton Dickinson, sold ~$94K of Becton Dickinson shares.

~$94K
Approx. value · 479 sh @ $197.28
4,887
Holds after · shares reported
Traded
Apr 9, 2025
Filed
Apr 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 10, 2025InsiderDirector purchased ~$350K of BDX shares in the open market
  2. Feb 12, 2025InsiderDirector sold ~$160K of BDX shares in the open market
  3. Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
  4. Mar 12, 2025InsiderOfficer sold ~$436K of BDX shares in the open market
  5. Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
  6. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  7. Apr 9, 2025 · this disclosureInsiderOfficer sold ~$94K of BDX shares in the open market

What came next

  1. May 13, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  2. May 15, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  3. Jun 2, 2025InsiderOfficer sold ~$200K of BDX shares in the open market
  4. Jun 27, 2025FDAFDA device clearance: BD Insyte™ Autoguard™ Shielded IV Catheter, BD Insyte™ Autoguard™ BC Shielded IV Catheter and BD Insyte™ Autoguard™ BC Pro Shielded IV Catheter
  5. Jul 3, 2025FDAFDA device clearance: BD Vacutainer® Eclipse™ Blood Collection Needle
  6. Jul 8, 2025FDARecall: BD Trucount Controls, 30 Test - REF: 664343, RxOnly, IVD
  7. Jul 8, 2025FDARecall: BD Trucount Controls, 30 Test - REF: 340335
  8. Jul 8, 2025FDARecall: BD Alaris Pump Infusion Sets REF: 10013186, BD Alaris Pump Infusion Set, Back Check Valve, 3 SmartSite Y-sites LVP 60D DEHP FREE 3SS CV; REF: 2452-0007, BD Ala…
  9. Jul 8, 2025FDARecall: BD Alaris Pump Module Model, 8100 with Guardrails, Suite MX software versions
  10. Jul 10, 2025FDAFDA device clearance: Marquee™ Disposable Core Biopsy Instrument and Instrument Kit
  11. Jul 10, 2025FDARecall: Description/REF: BD PYXIS MEDBANK MINI 1FH-1FM/169-137, BD PYXIS MEDBANK MINI 4HM/169-113, BD PYXIS MEDBANK MINI 4HH/169-112, BD PYXIS MEDBANK MINI 3HH-1HM/169…
  12. Jul 11, 2025FDAFDA device clearance: BD Cathena™ Safety IV Catheter
  13. Jul 17, 2025FDARecall: SureStep Foley Tray System Bardex I.C. Complete Care Infection Control Foley Catheter Tray, REF: A303316A
  14. Jul 17, 2025FDARecall: SureStep Foley Tray System Lubri-Sil I.C. Complete Care Infection Control Foley Catheter Tray, REF: A303414A
  15. Jul 17, 2025FDARecall: SureStep Foley Tray System BARD¿ Lubri-Sil Foley Catheter Tray, REF: A942216
  16. Jul 18, 2025Insider · 1 personInsiders: 2 sales (~$214K)
  17. Jul 24, 2025FDAFDA device clearance: Onflex™ Mesh
  18. Jul 25, 2025FDAFDA device clearance: BD Nexiva™ Closed IV Catheter System
  19. Jul 29, 2025FDAFDA device clearance: BD Plastipak™ Syringe
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Michael David Garrison, EVP & President, Medical

The full history of Michael David Garrison, EVP & President, Medical is on the profile page.

How this filing works

Explore the data

Common questions

Which Becton Dickinson (BDX) insider traded, and how much?

Michael David Garrison, Officer at Becton Dickinson, sold ~$94K of Becton Dickinson shares. 479 shares at $197.28.

When did it happen, and when was it made public?

Traded: Apr 9, 2025. Filed: Apr 10, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Becton Dickinson recently?

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.

Does this mean BDX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data